Next Article in Journal
Identification of Novel ARSB Genes Necessary for p-Benzoquinone Biosynthesis in the Larval Oral Secretion Participating in External Immune Defense in the Red Palm Weevil
Next Article in Special Issue
Lupenone Protects Neuroblastoma SH-SY5y Cells Against Methamphetamine-Induced Apoptotic Cell Death via PI3K/Akt/mTOR Signaling Pathway
Previous Article in Journal
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
Previous Article in Special Issue
A Pilot Study on the Effects of l-Carnitine and Trimethylamine-N-Oxide on Platelet Mitochondrial DNA Methylation and CVD Biomarkers in Aged Women
Open AccessArticle

Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones

1
MINT, UNIV Angers, INSERM 1066, CNRS 6021, IRIS-IBS-CHU, 4 Rue Larrey, 49100 Angers, France
2
SONAS, EA921, UNIV Angers, SFR QUASAV, Faculty of Health Sciences, Dpt Pharmacy, 16 Bd Daviers, 49045 Angers CEDEX 01, France
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(5), 1609; https://doi.org/10.3390/ijms21051609
Received: 31 January 2020 / Revised: 25 February 2020 / Accepted: 26 February 2020 / Published: 26 February 2020
Polyphenols consumption has been associated with a lower risk of cardiovascular diseases (CVDs) notably through nitric oxide (NO)- and estrogen receptor α (ERα)-dependent pathways. Among polyphenolic compounds, chalcones have been suggested to prevent endothelial dysfunction and hypertension. However, the involvement of both the NO and the ERα pathways for the beneficial vascular effects of chalcones has never been demonstrated. In this study, we aimed to identify chalcones with high vasorelaxation potential and to characterize the signaling pathways in relation to ERα signaling and NO involvement. The evaluation of vasorelaxation potential was performed by myography on wild-type (WT) and ERα knock-out (ERα-KO) mice aorta in the presence or in absence of the eNOS inhibitor Nω-nitro-L-arginine methyl ester (L-NAME). Among the set of chalcones that were synthesized, four (3, 8, 13 and 15) exhibited a strong vasorelaxant effect (more than 80% vasorelaxation) while five compounds (6, 10, 11, 16, 17) have shown a 60% relief of the pre-contraction and four compounds (12, 14, 18, 20) led to a lower vasorelaxation. We were able to demonstrate that the vasorelaxant effect of two highly active chalcones was either ERα-dependent and NO-independent or ERα-independent and NO-dependent. Thus some structure-activity relationships (SAR) were discussed for an optimized vasorelaxant effect. View Full-Text
Keywords: polyphenols; chalcones; structure-activity relationships; endothelium; vasodilation; cardiovascular diseases polyphenols; chalcones; structure-activity relationships; endothelium; vasodilation; cardiovascular diseases
Show Figures

Figure 1

MDPI and ACS Style

Legeay, S.; Trân, K.; Abatuci, Y.; Faure, S.; Helesbeux, J.-J. Novel Insights into the Mode of Action of Vasorelaxant Synthetic Polyoxygenated Chalcones. Int. J. Mol. Sci. 2020, 21, 1609.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop